Biomarkers, including imaging biomarkers, will be important for managing patients with Alzheimer's disease on disease-modifying drugs (DMD), such as Aduhelm and Leqembi, across the patient pathway.
Attending ECR 2023? Stop by our booth to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
AI in radiology is here to stay. The next challenge is ensuring it’s seamlessly integrated into radiologists’ and technicians’ imaging workflows. Read about these and other takeaways from RSNA 2022 in this blog post from Richard Hausmann, CEO; Lennart Thurfjell, COO; and Greg Kingston, CMO.
New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.
As the only company providing a complete imaging AI solution that goes beyond neurological image quantification to support the entire patient care pathway, we’re excited to share our platform and solutions at RSNA 2022!
Fountain Health announces 100 percent coverage of Combinostics cMRI and cDSI. The company is now the first and only health insurance platform to provide complete coverage for the AI-enabled neurological imaging and decision support solutions.
Dr. Erik Post and Dr. Hans-Peter Huber have joined Combinostics as Group Chief Financial Officer (CFO) and Vice President of European Sales, respectively. Their contributions include considerable experience scaling software solutions.
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
In this installment of our “Meet the Team” blog series, we talk to Erik Post, Group CFO of Combinostics, about his background and why he’s passionate about healthcare technology.
Attending the 14th Radiologie Kongress Ruhr (RKR)? Stop by booth 4.09 in Hall 1 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.